Figure 3A,B shows that the expression of cyclin B1, cyclin A, cell division cycle 2 (Cdc 2), cyclin-dependent kinase 2 (Cdk 2), and Cdc25c was reduced by BA treatment in all three bladder cancer cells dose-dependently. This evidence concerns the gene CDK2 and urinary bladder cancer.